B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS
暂无分享,去创建一个
D. Weisenburger | J. Cerhan | C. Flowers | N. Rothman | S. Chanock | P. Hartge | A. Brooks-Wilson | C. Skibola | G. Alarcón | S. Slager | P. Boffetta | E. Holly | Q. Lan | P. Bracci | Martyn T. Smith | P. Bhatti | P. Cocco | E. Brown | H. Hjalgrim | O. Martínez-Maza | Sophia S. Wang | O. Paltiel | A. D. De Roos | W. Cozen | B. Birmann | M. Linet | Y. Benavente | E. Roman | A. Kricker | J. Turner | A. Nieters | A. Monnereau | K. E. Smedby | C. Vajdic | J. Clavel | D. Casabonne | E. Breen | E. Kane | J. Voutsinas | M. Maynadié | Yawei Zhang | L. Foretova | T. Zheng | E. Brown
[1] J. Fellay,et al. Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma , 2019, Haematologica.
[2] M. Martinetti,et al. The Involvement of HLA Class II Alleles in Multiple Sclerosis: A Systematic Review with Meta-analysis , 2019, Disease markers.
[3] J. Cerhan,et al. Genetic overlap between autoimmune diseases and non‐Hodgkin lymphoma subtypes , 2019, Genetic epidemiology.
[4] E. Ben-Chetrit,et al. Shared Medical and Environmental Risk Factors in Dry Eye Syndrome, Sjogren's Syndrome, and B-Cell Non-Hodgkin Lymphoma: A Case-Control Study , 2019, Journal of immunology research.
[5] Stefano Monti,et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes , 2018, Nature Medicine.
[6] A. Younes,et al. High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma. , 2017, Blood reviews.
[7] Paolo Vineis,et al. Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia , 2016, Nature Communications.
[8] Angela Brooks-Wilson,et al. Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci. , 2015, American journal of epidemiology.
[9] Paolo Vineis,et al. A genome-wide association study of marginal zone lymphoma shows association to the HLA region , 2015, Nature Communications.
[10] Paolo Vineis,et al. Genome-wide association study identifies multiple susceptibility loci for diffuse large B-cell lymphoma , 2014, Nature Genetics.
[11] D. Weisenburger,et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. , 2014, Journal of the National Cancer Institute. Monographs.
[12] Paolo Vineis,et al. Genome-wide Association Study Identifies Multiple Risk Loci for Chronic Lymphocytic Leukemia , 2013, Nature Genetics.
[13] Adele Seniori Costantini,et al. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. , 2010, Blood.
[14] S. Baranzini,et al. Genetic variation in the odorant receptors family 13 and the mhc loci influence mate selection in a multiple sclerosis dataset , 2010, BMC Genomics.
[15] D. Hémon,et al. Increased frequency of hematopoietic malignancies in relatives of patients with lymphoid neoplasms: A French case–control study , 2009, International journal of cancer.
[16] J. Cerhan,et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. , 2008, Blood.
[17] B. Ponder,et al. Polygenes, risk prediction, and targeted prevention of breast cancer. , 2008, The New England journal of medicine.
[18] J. Cerhan,et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. , 2008, Blood.
[19] R. Gascoyne,et al. Organochlorines and risk of non‐Hodgkin lymphoma , 2007, International journal of cancer.
[20] D. Weisenburger,et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). , 2007, Blood.
[21] E. Holly,et al. Residential History, Family Characteristics and Non–Hodgkin Lymphoma, A Population-Based Case-Control Study in the San Francisco Bay Area , 2006, Cancer Epidemiology Biomarkers & Prevention.
[22] H. Adami,et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. , 2006, Journal of the National Cancer Institute.
[23] J. Cerhan,et al. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study. , 2005, American journal of epidemiology.
[24] J. Kaldor,et al. Sun exposure may protect against non‐Hodgkin lymphoma: A case‐control study , 2004, International journal of cancer.
[25] J. Cerhan,et al. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[26] M. Forrest,et al. Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[27] P. Boyle,et al. Prior Medical Conditions and Medication use and Risk of non-Hodgkin lymphoma in Connecticut United States Women , 2004, Cancer Causes & Control.
[28] E. Holly,et al. Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco. , 2003, American journal of epidemiology.
[29] A. Silman,et al. Epidemiology and genetics of rheumatoid arthritis , 2002, Arthritis research.
[30] O. Nanni,et al. Haematopoietic cancer and medical history: a multicentre case control study , 2000, Journal of epidemiology and community health.
[31] P. Donnelly,et al. Inference of population structure using multilocus genotype data. , 2000, Genetics.
[32] S. Franceschi,et al. Medical history and risk of Hodgkin's and non‐Hodgkin's lymphomas , 2000, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[33] J. Cerhan,et al. Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. , 2014, Journal of the National Cancer Institute. Monographs.
[34] J. Cerhan,et al. Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. , 2014, Journal of the National Cancer Institute. Monographs.
[35] D. Weisenburger,et al. Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. , 2014, Journal of the National Cancer Institute. Monographs.
[36] J. Cerhan,et al. Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma. , 2011, International journal of molecular epidemiology and genetics.
[37] T. Rüdiger,et al. Medical history and risk for lymphoma: results of a population-based case-control study in Germany. , 2005, European journal of cancer.
[38] Cdm Fletcher,et al. World Health Organization Classification of Tumours , 2002 .
[39] Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region , 2022 .